FDA Clears AI Tool for Coronary Plaque Analysis
The clearance enables on-premise AI analysis of coronary CT angiography for quantifying calcified and non-calcified plaque.
The clearance enables on-premise AI analysis of coronary CT angiography for quantifying calcified and non-calcified plaque.
Blindly deploying vendor patches can sideline critical devices and jeopardize patient safety.
Boston Scientific’s Endotak Reliance leads with ePTFE-coated coils may reduce shock efficacy due to coil calcification.
The clearance enables on-premise AI analysis of coronary CT angiography for quantifying calcified and non-calcified plaque.
Effective stakeholder analysis and requirements gathering are critical to safe, compliant infusion system design.
Read MoreThe platforms, which switch between radiography and fluoroscopy applications, enable remote and tableside exams and feature AI-powered workflows.
Read MoreThe Class I recall involves devices with incorrectly assembled B/V filters.
Read MoreUse with select infusion sets may lead to over- or under-infusion, bolus inaccuracies, and alarm delays, BD warns in recall notice.
Read MoreThe FDA has cleared a new home airway clearance system that synchronizes breathing with chest compressions to support patients with chronic lung diseases such as COPD, cystic fibrosis, and bronchiectasis.
Read MoreAAMI intends to leverage the code to inform its work addressing the use of AI and machine learning in medical devices.
Read More
The system allows US healthcare providers to transform traditional 2D ultrasound into AI-supported 3D tomographic imaging.Â